# Innovative Treatments in Pneumonia (ITIP) 3

> **NCT02960919** · — · COMPLETED · sponsor: **Save the Children** · enrollment: 1001 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** oral amoxicillin or parenteral ampicillin/ penicillin and gentamicin
- **DRUG:** parenteral ampicillin/ penicillin
- **DRUG:** gentamicin

## Key facts

- **NCT ID:** NCT02960919
- **Lead sponsor:** Save the Children
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-19
- **Primary completion:** 2018-06
- **Final completion:** 2018-07
- **Target enrollment:** 1001 (ACTUAL)
- **Last updated:** 2021-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02960919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02960919, "Innovative Treatments in Pneumonia (ITIP) 3". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02960919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*